GENETIC POLYMORPHISMS IN SLCO1B1 ARE NOT ASSOCIATED WITH ALTERED VOXILAPREVIR EXPOSURE.

被引：0
|
作者：
Garrison, K. [1 ]
Song, Q. [1 ]
Stamm, L. [1 ]
Ling, J. [1 ]
Mathias, A. [1 ]
机构：
[1] Gilead Sci, Foster City, CA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-073
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [21] The impact of SLCO1B1 genetic polymorphisms on neonatal hyperbilirubinemia: a systematic review with meta-analysis
    Liu, Jiebo
    Long, Jun
    Zhang, Shaofang
    Fang, Xiaoyan
    Luo, Yuyuan
    JORNAL DE PEDIATRIA, 2013, 89 (05) : 434 - 443
  • [22] Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole-induced liver injury
    Jin, Shasha
    Li, Xuesong
    Fan, Yujuan
    Fan, Xiaofang
    Dai, Yu
    Lin, Haishu
    Cai, Weimin
    Yang, Jialin
    Xiang, Xiaoqiang
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 (06) : 508 - 517
  • [23] Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure
    Seiko Endo
    Aiko Fukahori
    Shinya Tokuhiro
    Akira Shinagawa
    Joseph Walker
    Kazutaka Yoshihara
    Hitoshi Ishizuka
    Ichiro Ieiri
    Yuichi Sugiyama
    Journal of Human Genetics, 2012, 57 : 531 - 544
  • [24] Genetic Variations and Frequencies of the Two Functional Single Nucleotide Polymorphisms of SLCO1B1 in the Thai Population
    Nakorn, Chalitpon Na
    Waisayarat, Jariya
    Dejthevaporn, Charungthai
    Srisawasdi, Pornpen
    Wongwaisayawan, Sansanee
    Sukasem, Chonlaphat
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [25] Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure
    Endo, Seiko
    Fukahori, Aiko
    Tokuhiro, Shinya
    Shinagawa, Akira
    Walker, Joseph
    Yoshihara, Kazutaka
    Ishizuka, Hitoshi
    Ieiri, Ichiro
    Sugiyama, Yuichi
    JOURNAL OF HUMAN GENETICS, 2012, 57 (08) : 531 - 544
  • [26] PharmVar GeneFocus: SLCO1B1
    Ramsey, Laura B.
    Gong, Li
    Lee, Seung-Been
    Wagner, Jonathan B.
    Zhou, Xujia
    Sangkuhl, Katrin
    Adams, Solomon M.
    Straka, Robert J.
    Empey, Philip E.
    Boone, Erin C.
    Klein, Teri E.
    Niemi, Mikko
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (04) : 782 - 793
  • [27] UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association?
    Laura Alencastro de Azevedo
    Themis Reverbel da Silveira
    Clarissa Gutierrez Carvalho
    Simone Martins de Castro
    Roberto Giugliani
    Ursula Matte
    Pediatric Research, 2012, 72 : 169 - 173
  • [28] Influence of SLCO1B1 and SLCO2B1 Polymorphisms on Tacrolimus Pharmacokinetics and Clinical Efficacy and Safety.
    Alves, C.
    Felipe, C.
    Nishikawa, A.
    Salgado, P.
    Fajardo, C.
    Spinelli, G.
    Tedesco, H.
    Medina-Pestana, J.
    Hirata, M.
    Hirata, R.
    Rodrigues, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 503 - 503
  • [29] SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population
    Rattanacheeworn, Punyabhorn
    Chamnanphon, Monpat
    Thongthip, Siriwan
    Kittanamongkolchai, Wonngarm
    Townamchai, Natavudh
    Avihingsanon, Yingyos
    Udomnilobol, Udomsak
    Prueksaritanont, Thomayant
    Jianmongkol, Suree
    Chariyavilaskul, Pajaree
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2020, 13 : 521 - 530
  • [30] SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria
    Sortica, Vinicius A.
    Lindenau, Juliana D.
    Cunha, Maristela G.
    Ohnishi, Maria Deise O.
    Ventura, Ana Maria R.
    Ribeiro-dos-Santos, A. ndrea K. C.
    Santos, Sidney E. B.
    Guimaraes, Luciano S. P.
    Hutz, Mara H.
    PHARMACOGENOMICS, 2017, 18 (15) : 1401 - 1411
12345